253 related articles for article (PubMed ID: 15640693)
1. Perspectives of gene therapy for primary immunodeficiencies.
Chinen J; Puck JM
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):523-7. PubMed ID: 15640693
[TBL] [Abstract][Full Text] [Related]
2. Ten years of gene therapy for primary immune deficiencies.
Aiuti A; Roncarolo MG
Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy Approaches to Immunodeficiency.
Ghosh S; Gaspar HB
Hematol Oncol Clin North Am; 2017 Oct; 31(5):823-834. PubMed ID: 28895850
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for inherited immunodeficiency.
Touzot F; Hacein-Bey-Abina S; Fischer A; Cavazzana M
Expert Opin Biol Ther; 2014 Jun; 14(6):789-98. PubMed ID: 24823313
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for PIDs: progress, pitfalls and prospects.
Mukherjee S; Thrasher AJ
Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vectors for the treatment of primary immunodeficiencies.
Farinelli G; Capo V; Scaramuzza S; Aiuti A
J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of inherited immunodeficiencies.
Santilli G; Thornhill SI; Kinnon C; Thrasher AJ
Expert Opin Biol Ther; 2008 Apr; 8(4):397-407. PubMed ID: 18352845
[TBL] [Abstract][Full Text] [Related]
9. Evolving Gene Therapy in Primary Immunodeficiency.
Thrasher AJ; Williams DA
Mol Ther; 2017 May; 25(5):1132-1141. PubMed ID: 28366768
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for primary immunodeficiencies: current status and future prospects.
Qasim W; Gennery AR
Drugs; 2014 Jun; 74(9):963-9. PubMed ID: 24848753
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy of primary immunodeficiencies.
Fischer A; De Saint Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
Adv Nephrol Necker Hosp; 1997; 26():107-20. PubMed ID: 8922128
[No Abstract] [Full Text] [Related]
12. Successes and risks of gene therapy in primary immunodeficiencies.
Chinen J; Puck JM
J Allergy Clin Immunol; 2004 Apr; 113(4):595-603; quiz 604. PubMed ID: 15100660
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.
Candotti F
Int J Hematol; 2014 Apr; 99(4):383-92. PubMed ID: 24488786
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of primary T cell immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
[TBL] [Abstract][Full Text] [Related]
15. [Current status and future prospects of stem cell gene therapy for primary immunodeficiency].
Uchiyama T; Onodera M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):148-55. PubMed ID: 23812072
[TBL] [Abstract][Full Text] [Related]
16. Primary immunodeficiencies: molecular aspects and treatment.
Fischer A
Bone Marrow Transplant; 1992; 9 Suppl 1():39-43. PubMed ID: 1354525
[No Abstract] [Full Text] [Related]
17. Gene therapy for adenosine deaminase deficiency.
Cappelli B; Aiuti A
Immunol Allergy Clin North Am; 2010 May; 30(2):249-60. PubMed ID: 20493400
[TBL] [Abstract][Full Text] [Related]
18. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
[TBL] [Abstract][Full Text] [Related]
19. Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.
Carriglio N; Klapwijk J; Hernandez RJ; Vezzoli M; Chanut F; Lowe R; Draghici E; Nord M; Albertini P; Cristofori P; Richards J; Staton H; Appleby J; Aiuti A; Sauer AV
Hum Gene Ther Clin Dev; 2017 Mar; 28(1):17-27. PubMed ID: 28319446
[TBL] [Abstract][Full Text] [Related]
20. Progress and prospects: gene therapy for inherited immunodeficiencies.
Qasim W; Gaspar HB; Thrasher AJ
Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
